The world-second developed shingles vaccine ‘SKYZoster™’ is authorized by the Nationwide Pharmaceutical Regulatory Company (NPRA) SK biosciences plans to launch the zoster vaccine with confirmed efficacy and security beginning in Southeast Asian market SEOUL, South...